Q&A with N-SIDE’s Sébastien Coppe: how digitisation overcomes clinical bottlenecks
The Covid-19 pandemic has transformed clinical development. Rather than taking ten years to bring a drug to market, vaccine…
By
Allie Nawrat
All Articles
Treatment-resistant rare diseases: exploring landmark drug approvals in 2020
Rare disease drug development poses such serious challenges that only 5% of rare diseases have a treatment. However, this…
ByCoronavirus company news summary
16 April 2020 Japan’s Fujifilm has expanded manufacturing capacity to boost production of its influenza drug Avigan that is…
ByAligos to leverage Luxna’s tech to create anti-viral drugs
Aligos Therapeutics has broadened its license agreement with Osaka University’s Luxna Biotech to develop anti-viral drugs against the virus…
By
Exploring efficiencies from eTMF with Cancer Research UK
Creating electronic versions of documents and processes underlying clinical trials is becoming the norm. Cancer Research UK’s Stephen Nabarro…
By
FDA accepts BLA from AstraZeneca and Daiichi for targeted chemotherapy
AstraZeneca and Daiichi Sankyo have announced that the US Food and Drug Administration (FDA) has accepted their biologics license…
By